Studies&Me-arkiv - BioStock

Coegin Pharma aims high in 2022

Coegin Pharma aims high in 2022

18 January, 2022

Coegin Pharma takes key steps for growth during Q3

Coegin Pharma takes key steps for growth during Q3

30 November, 2021

Coegin Study Approval

Coegin Pharma receives final approval for COAK Study

26 October, 2021

Coegin Pharma – generating value and reducing risk in 2021

7 May, 2021

Coegin Pharma takes advantage of decentralised clinical trials

19 April, 2021

Coegin Pharma submits clinical study application

12 March, 2021

Coegin Pharma’s clinical development in actinic keratosis

25 February, 2021